13F filer · CIK 1562230 ↗
Capital International Investors
You are looking at Q2 2022. See the latest, Q2 2026 →
Reported value
$367.64B
−16% on the quarter before
Positions
437
16 new · 33 sold out
Top 10
26.7%
of the value
Est. gain
−$66.15B
on stocks held all quarter
Est. return
−16.0%
on those stocks since Q1 2022
Positions as of Jun 30, 2022, from Capital International Investors's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 41% of the reported value, each sized by its share, colored by what the fund did with it since Q1 2022. Striped tiles are options.
Largest buys
Since Q1 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Abbvie Inc~$1.94BAdded · 1.1% → 1.8%+12,657,354 shares
- Bristol-Myers Squibb Co~$1.17BAdded · 0.4% → 0.8%+15,196,981 shares
- Albemarle Corp~$694.2MNew · 0.0% → 0.2%+3,322,014 shares
- Vici Pptys Inc~$599.2MAdded · 0.4% → 0.6%+20,113,472 shares
- First Rep Bk San Francisco C~$576.5MAdded · 0.3% → 0.5%+3,997,877 shares
- Pfizer Inc~$571.5MAdded · 0.5% → 0.7%+10,900,979 shares
- Philip Morris Intl Inc~$555.7MAdded · 1.6% → 2.2%+5,626,844 shares
- Yum Brands Inc~$488.2MAdded · 0.1% → 0.3%+4,300,578 shares
- Qualcomm~$454.6MAdded · 0.3% → 0.4%+3,558,464 shares
- United Parcel Service Inc~$444.4MAdded · 0.4% → 0.5%+2,434,318 shares
Largest sells
Since Q1 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Eli Lilly~$1.26BCut · 0.6% → 0.4%−3,877,256 shares
- Netflix~$821.8MCut · 1.6% → 0.7%−4,699,324 shares
- Meta~$728.6MCut · 2.7% → 2.2%−4,518,349 shares
- Eog Res Inc~$712.2MCut · 1.0% → 0.9%−6,446,927 shares
- Truist Finl Corp~$656.3MCut · 0.5% → 0.3%−13,837,380 shares
- Intercontinental Exchange In~$616.1MCut · 0.5% → 0.3%−6,547,377 shares
- Lyondellbasell Industries N~$567.4MCut · 0.7% → 0.5%−6,487,458 shares
- Vale S A~$560.4MCut · 0.7% → 0.5%−38,277,716 shares
- Applied Materials~$534.9MCut · 0.7% → 0.5%−5,879,417 shares
- L3harris Technologies Inc~$448.0MCut · 0.2% → 0.1%−1,855,097 shares
Holdings
As of Jun 30, 2022. Changes are in shares against Mar 31, 2022, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares −1.8% · price −16.7% | 5.9% | $21.86B | −$4.38B | ||||||||
| BroadcomCOM · shares −2.3% · price −22.8% | 3.9% | $14.19B | −$4.20B | ||||||||
| Unitedhealth Group IncCOM · shares −2.9% · price +0.7% | 2.5% | $9.31B | +$64.7M | ||||||||
| AlphabetCAP STK CL C · shares −2.0% · price −21.7% | 2.3% | $8.31B | −$2.30B | ||||||||
| Comcast Corp NewCL A · shares +2.1% · price −16.2% | 2.2% | $8.13B | −$1.54B | ||||||||
| Philip Morris Intl IncCOM · shares +7.4% · price +5.1% | 2.2% | $8.04B | +$365.0M | ||||||||
| MetaCL A · shares −8.4% · price −27.5% | 2.2% | $7.99B | −$3.03B | ||||||||
| AmazonCOM · shares −0.2% · price −38.1% | 2.2% | $7.93B | −$4.88B | ||||||||
| Abbvie IncCOM · shares +42% · price −5.5% | 1.8% | $6.61B | −$272.9M | ||||||||
| Northrop Grumman CorpCOM · shares −1.3% · price +7.0% | 1.6% | $5.87B | +$381.9M | ||||||||
| Abbott LabsCOM · shares +0.5% · price −8.2% | 1.5% | $5.49B | −$488.4M | ||||||||
| MastercardCL A · shares +0.3% · price −11.7% | 1.4% | $5.13B | −$679.6M | ||||||||
| Raytheon Technologies CorpCOM · shares +6.2% · price −3.0% | 1.1% | $4.20B | −$122.9M | ||||||||
| ConocophillipsCOM · shares −8.7% · price −10.2% | 1.1% | $4.07B | −$461.4M | ||||||||
| Charter Communications Inc NCL A · shares +3.5% · price −14.1% | 1.1% | $3.97B | −$631.5M | ||||||||
| Chubb LimitedCOM · shares −0.4% · price −8.1% | 1.1% | $3.95B | −$349.5M | ||||||||
| Transdigm Group IncCOM · shares −0.3% · price −17.6% | 0.95% | $3.51B | −$751.7M | ||||||||
| Eog Res IncCOM · shares −17% · price −7.4% | 0.95% | $3.48B | −$276.3M | ||||||||
| Johnson & JohnsonCOM · shares −2.6% · price +0.2% | 0.94% | $3.46B | +$5.3M | ||||||||
| Jpmorgan Chase & CoCOM · shares −6.5% · price −17.4% | 0.93% | $3.43B | −$723.0M | ||||||||
| AlphabetCAP STK CL A · shares +1.0% · price −21.6% | 0.92% | $3.38B | −$923.9M | ||||||||
| IntelCOM · shares −8.5% · price −24.5% | 0.89% | $3.28B | −$1.07B | ||||||||
| AppleCOM · shares −4.4% · price −21.7% | 0.88% | $3.23B | −$895.5M | ||||||||
| Marsh & Mclennan Cos IncCOM · shares +0.3% · price −8.9% | 0.87% | $3.21B | −$313.4M | ||||||||
| Chevron Corp NewCOM · shares −9.1% · price −11.1% | 0.86% | $3.17B | −$395.0M | ||||||||
| Total · 437 positions | 100% | $367.64B | −$66.15B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2022 to Q2 2022: 420 stocks held throughout, down $66.15B (−16.0%).
- Seagen Inc+$509.8M+23%
- Northrop Grumman Corp+$381.9M+7%
- Philip Morris Intl Inc+$365.0M+5%
- General Mls Inc+$267.0M+11%
- Dollar Gen Corp New+$196.3M+10%
- Netflix−$2.75B−53%
- Meta−$3.03B−27%
- Broadcom−$4.20B−23%
- Microsoft−$4.38B−17%
- Amazon19:1 split−$4.88B−38%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 1 split read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $483.61B+13% | SEC ↗ |
| Q1 2026 | May 13, 2026 | $426.52B−33% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $637.97B+3% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $619.40B+7% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $580.56B+14% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $508.52B−4% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $532.30B+2% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $520.97B+7% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $485.73B−2% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $493.90B+11% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $446.09B+13% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $394.11B−5% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $414.45B+7% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $388.71B+4% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $372.54B+9% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $342.83B−7% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $367.64B−16% | SEC ↗ |
| Q1 2022 | May 19, 2022 (amended) | $438.61B−7% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $473.03B+8% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $437.44B−0% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $437.89B+11% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $395.24B+8% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $366.38B+13% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $323.46B+6% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $305.21B+25% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $244.50B−17% | SEC ↗ |
| Q4 2019 | Feb 18, 2020 | $294.42B+12% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $261.94B+5% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $250.64B+8% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $232.80B+16% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $200.60B−8% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $218.36B+147% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $88.55B+2% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $86.51B−2% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $88.52B+6% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $83.48B+11% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $74.88B+2% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $73.61B+6% | SEC ↗ |
| Q4 2016 | Feb 15, 2017 | $69.28B+0% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $68.95B+1% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $68.21B+5% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $65.22B | SEC ↗ |